Stockscreener 앱 받기
3.27
3.48%
0.11
시장 영업 전:
3.21
-0.06
-1.83%
전일 마감가:
$3.16
열려 있는:
$3.14
하루 거래량:
5.16M
Relative Volume:
1.63
시가총액:
$892.04M
수익:
$8.10M
순이익/손실:
$-92.72M
주가수익비율:
-9.6176
EPS:
-0.34
순현금흐름:
$-82.52M
1주 성능:
+11.99%
1개월 성능:
+11.99%
6개월 성능:
+135.25%
1년 성능:
+62.69%
1일 변동 폭
$3.11
$3.30
1주일 범위
$2.91
$3.30
52주 변동 폭
$1.05
$3.40
Taysha Gene Therapies Inc Stock (TSHA) Company Profile
명칭
Taysha Gene Therapies Inc
전화
(214) 612-0000
주소
3000 PEGASUS PARK DRIVE, DALLAS
TSHA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TSHA
Taysha Gene Therapies Inc
|
3.27 | 862.03M | 8.10M | -92.72M | -82.52M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-11 | 개시 | BofA Securities | Buy |
| 2024-06-27 | 개시 | BMO Capital Markets | Outperform |
| 2024-04-09 | 개시 | Piper Sandler | Overweight |
| 2023-02-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-01-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-03-09 | 개시 | Robert W. Baird | Outperform |
| 2022-03-01 | 개시 | Wells Fargo | Overweight |
| 2022-02-18 | 개시 | SMBC Nikko | Outperform |
| 2021-12-16 | 개시 | Guggenheim | Buy |
| 2021-07-16 | 개시 | Needham | Buy |
| 2021-06-24 | 개시 | Truist | Buy |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-06-09 | 개시 | Wedbush | Outperform |
| 2021-06-08 | 개시 | JMP Securities | Mkt Outperform |
| 2021-05-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-05-11 | 재개 | Jefferies | Buy |
| 2021-02-24 | 개시 | William Blair | Outperform |
| 2021-01-05 | 개시 | Oppenheimer | Outperform |
| 2020-10-19 | 개시 | Chardan Capital Markets | Buy |
| 2020-10-19 | 개시 | Goldman | Buy |
| 2020-10-19 | 개시 | Jefferies | Buy |
| 2020-10-19 | 개시 | Morgan Stanley | Overweight |
모두보기
Taysha Gene Therapies Inc 주식(TSHA)의 최신 뉴스
Will Taysha Gene Therapies Inc. stock continue dividend increasesPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com
How to interpret RSI for Taysha Gene Therapies Inc. stockMarket Activity Report & Consistent Profit Trading Strategies - newser.com
Will Taysha Gene Therapies Inc. stock maintain growth storyWall Street Watch & Risk Managed Investment Signals - newser.com
Analyzing drawdowns of Taysha Gene Therapies Inc. with statistical toolsEarnings Growth Summary & Stepwise Swing Trade Plans - newser.com
Taysha Gene Therapies (NASDAQ:TSHA) Trading Down 4.5%Time to Sell? - MarketBeat
Is Taysha Gene Therapies Inc. trending in predictive chart modelsWeekly Trade Summary & Weekly Stock Performance Updates - newser.com
What analysts say about Taysha Gene Therapies Inc stockDouble Top/Bottom Patterns & Turn Data into Profits With Our Strategies - earlytimes.in
Should You Track Rapid Investments Limited as a LongTerm Growth PlayWeekly Market Snapshot & Grow Smarter With Pro-Level Research - Early Times
What drives Taysha Gene Therapies Inc stock priceCapital Gains Strategies & Rapid Profit Portfolio - earlytimes.in
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Taysha Gene Therapies, Inc. $TSHA Shares Sold by Goldman Sachs Group Inc. - MarketBeat
Taysha Gene Therapies, Inc. Experiences Revision in Stock Evaluation Amid Strong Performance - Markets Mojo
Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 8%Time to Buy? - MarketBeat
Cantor Fitzgerald reiterates Overweight rating on Taysha Gene Therapies stock - Investing.com
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Down 4.4% on Insider Selling - MarketBeat
Combining price and volume data for Taysha Gene Therapies Inc.M&A Rumor & Long-Term Safe Investment Ideas - newser.com
Sentiment analysis tools applied to Taysha Gene Therapies Inc.Earnings Growth Summary & Expert Curated Trade Setup Alerts - newser.com
Bank Watch: Can TNONW maintain its current growth rateWeekly Trade Recap & Technical Pattern Based Signals - khodrobank.com
Is this a good reentry point in Taysha Gene Therapies Inc.2025 Market Trends & Long Hold Capital Preservation Plans - newser.com
Breakout Watch: What is the next catalyst for Taysha Gene Therapies IncJuly 2025 Movers & Daily Volume Surge Trade Alerts - خودرو بانک
Is Taysha Gene Therapies Inc. building a consolidation baseShort Setup & Capital Efficient Trade Techniques - newser.com
Live market analysis of Taysha Gene Therapies Inc.2025 Top Gainers & Smart Allocation Stock Tips - newser.com
Taysha Gene Therapies, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Insider Selling: Taysha Gene Therapies (NASDAQ:TSHA) Insider Sells 200,000 Shares of Stock - MarketBeat
Siren L.L.C. Has $9.06 Million Stock Holdings in Taysha Gene Therapies, Inc. $TSHA - MarketBeat
Downgrade Watch: How liquid is Taysha Gene Therapies Inc stockQuarterly Market Summary & Reliable Price Breakout Alerts - خودرو بانک
Published on: 2025-09-16 23:25:17 - خودرو بانک
Tech Rally: Will Taysha Gene Therapies Inc benefit from AI trendsProfit Target & Consistent Growth Equity Picks - خودرو بانک
Returns Recap: How correlated is Taysha Gene Therapies Inc to the S P5002025 Top Gainers & Precise Entry and Exit Recommendations - خودرو بانک
Risk Hedge: Is QUAD stock a falling knife or bargain buyJuly 2025 Sector Moves & Real-Time Market Trend Scan - خودرو بانک
Insider Buy: Is Taysha Gene Therapies Inc attractive for institutional investors2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - خودرو بانک
Quarterly Recap: Is Taysha Gene Therapies Inc. subject to activist investor interestOptions Play & Community Consensus Trade Signals - خودرو بانک
Aug Mood: What is the next catalyst for Taysha Gene Therapies IncJuly 2025 Update & Daily Growth Stock Tips - khodrobank.com
Quarterly Recap: How liquid is Taysha Gene Therapies Inc. stockQuarterly Market Summary & AI Driven Stock Reports - خودرو بانک
How to read the order book for Taysha Gene Therapies Inc.Market Risk Report & Verified Technical Trade Signals - newser.com
Taysha Gene Therapies, Inc. $TSHA Shares Purchased by Octagon Capital Advisors LP - MarketBeat
Screener Results Flag Taysha Gene Therapies Inc. as OversoldTrade Risk Summary & Verified Entry Point Signals - beatles.ru
Nuveen LLC Acquires New Holdings in Taysha Gene Therapies, Inc. $TSHA - MarketBeat
ADAR1 Capital Management LLC Purchases 888,602 Shares of Taysha Gene Therapies, Inc. $TSHA - MarketBeat
Published on: 2025-09-06 13:01:15 - Newser
Real time breakdown of Taysha Gene Therapies Inc. stock performance2025 Analyst Calls & Momentum Based Trading Signals - Newser
Volume Report: Is Taysha Gene Therapies Inc. benefiting from interest rate changesJuly 2025 Highlights & Low Risk High Reward Ideas - خودرو بانک
Taysha Gene Therapies Inc. stock prediction for this weekJobs Report & Verified Short-Term Plans - Newser
Aug Highlights: Can Taysha Gene Therapies Inc. outperform under higher oil pricesEarnings Growth Report & Fast Moving Stock Watchlists - خودرو بانک
Published on: 2025-09-05 16:05:08 - Newser
What institutional flow reveals about Taysha Gene Therapies Inc.2025 Winners & Losers & Daily Profit Focused Screening - Newser
Is Taysha Gene Therapies Inc. stock entering bullish territoryQuarterly Market Review & Comprehensive Market Scan Reports - Newser
Trapped Investors in Taysha Gene Therapies Inc. Await Breakout SignalJuly 2025 Momentum & Consistent Growth Equity Picks - beatles.ru
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule 5635(c)(4) - MarketScreener
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule - TipRanks
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Li - GuruFocus
Taysha Gene Therapies Inc (TSHA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
1.10%
자본화:
|
볼륨(24시간):